CEL-SCI Corp (CVM)
1.48
-0.03
(-1.99%)
USD |
NYAM |
May 10, 12:35
CEL-SCI Enterprise Value: 78.27M for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 78.27M |
| May 08, 2024 | 71.79M |
| May 07, 2024 | 86.90M |
| May 06, 2024 | 89.60M |
| May 03, 2024 | 84.74M |
| May 02, 2024 | 76.65M |
| May 01, 2024 | 73.41M |
| April 30, 2024 | 75.57M |
| April 29, 2024 | 72.87M |
| April 26, 2024 | 74.49M |
| April 25, 2024 | 75.03M |
| April 24, 2024 | 75.57M |
| April 23, 2024 | 76.11M |
| April 22, 2024 | 78.27M |
| April 19, 2024 | 80.97M |
| April 18, 2024 | 77.73M |
| April 17, 2024 | 77.73M |
| April 16, 2024 | 78.81M |
| April 15, 2024 | 82.59M |
| April 12, 2024 | 84.74M |
| April 11, 2024 | 86.36M |
| April 10, 2024 | 86.90M |
| April 09, 2024 | 89.06M |
| April 08, 2024 | 92.84M |
| April 05, 2024 | 92.30M |
| Date | Value |
|---|---|
| April 04, 2024 | 90.68M |
| April 03, 2024 | 96.62M |
| April 02, 2024 | 93.38M |
| April 01, 2024 | 95.54M |
| March 28, 2024 | 99.86M |
| March 27, 2024 | 98.78M |
| March 26, 2024 | 98.24M |
| March 25, 2024 | 84.74M |
| March 22, 2024 | 95.54M |
| March 21, 2024 | 98.78M |
| March 20, 2024 | 103.64M |
| March 19, 2024 | 106.34M |
| March 18, 2024 | 107.42M |
| March 15, 2024 | 105.26M |
| March 14, 2024 | 110.65M |
| March 13, 2024 | 108.50M |
| March 12, 2024 | 110.65M |
| March 11, 2024 | 116.05M |
| March 08, 2024 | 120.37M |
| March 07, 2024 | 119.83M |
| March 06, 2024 | 126.85M |
| March 05, 2024 | 117.13M |
| March 04, 2024 | 121.45M |
| March 01, 2024 | 117.67M |
| February 29, 2024 | 109.04M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
46.60M
Minimum
Oct 20 2023
1.105B
Maximum
Apr 27 2021
297.59M
Average
236.81M
Median
Jun 25 2019
Enterprise Value Benchmarks
| Synlogic Inc | -26.43M |
| BioXcel Therapeutics Inc | 120.74M |
| IGM Biosciences Inc | 257.24M |
| Intelligent Bio Solutions Inc | 4.662M |
| Syra Health Corp | 6.818M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.710M |
| Total Expenses (Quarterly) | 6.486M |
| EPS Diluted (Quarterly) | -0.14 |
| Earnings Yield | -45.95% |